MicroPort Scientific : ® NeuroTech™ Announces Publication of Safety Study Results for Tubridge™ in Treating Intracranial Aneurysms -April 03, 2024 at 10:02 am EDT marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
A stem cell-based bio-artificial liver therapy developed by scientists in China has received approval for clinical trials. Groundbreaking therapy system: The Chinese research team, led by Dr. Gao Yi from the Translational Medicine Centre at Zhujiang Hospital of Southern Medical University, developed the bio-artificial liver system that uses a bioreactor to perform the essential functions of the liver, such as detoxification and protein synthesis, outside the body. Deadly disease: Liver disease is responsible for 4% of all deaths, accounting for 2 million fatalities around the world each year.